Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rituximab biosimilar RTXM83 versus reference rituximab in combination with CHOP as first-line treatment for diffuse large B-cell lymphoma: a randomized, double-blind study.
Candelaria M, González DE, Delamain MT, Bär DO, Beniwal SK, Dasappa L, Flores DH, Querol J, Guan TS, Lipatov ON, Volodicheva EM, Patel M, Safaee Nodehi SR, Fogliatto L, Paravisini A, Perez Diaz L; RTXM83 study. Candelaria M, et al. Among authors: volodicheva em. Leuk Lymphoma. 2019 Dec;60(14):3375-3385. doi: 10.1080/10428194.2019.1633632. Epub 2019 Jul 4. Leuk Lymphoma. 2019. PMID: 31272251 Free article. Clinical Trial.
[Risk - adapted intensive induction therapy, autologous stem cell transplantation, and rituximab maintenance allow to reach a high 7-year survival rate in patients with mantle cell lymphoma].
Vorobyev VI, Gemdzhian EG, Dubrovin EI, Nesterova ES, Kaplanov KD, Volodicheva EM, Zherebtsova VA, Kravchenko SK. Vorobyev VI, et al. Among authors: volodicheva em. Ter Arkh. 2019 Jul 15;91(7):41-51. doi: 10.26442/00403660.2019.07.000322. Ter Arkh. 2019. PMID: 32598735 Russian.
[The first results of treatment for adult acute myeloid leukemia according to the AML-01.10 protocol of the Research Group of the Hematology Centers of Russia].
Parovichnikova EN, Kliasova GA, Sokolov AN, Troitskaia VV, Kokhno AV, Kuz'mina LA, Shaforostova II, Ryzhko VV, Kravchenko SK, Bondarenko SN, Lapin VA, Pristupa AS, Konstantinova TS, Zagoskina TP, Ialykomov IV, Moskov VI, Anchukova LV, Kaporskaia TS, Volodicheva EM, Kaplanov KD, Kondakova EV, Samoĭlova OS, Gavrilova LV, Kulikov SM, Savchenko VG. Parovichnikova EN, et al. Among authors: volodicheva em. Ter Arkh. 2012;84(7):10-5. Ter Arkh. 2012. PMID: 23038965 Clinical Trial. Russian.